173 related articles for article (PubMed ID: 36221419)
21. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
22. Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.
Lin H; Wu Y; Liang G; Chen L
PLoS One; 2020; 15(11):e0242155. PubMed ID: 33170907
[TBL] [Abstract][Full Text] [Related]
23. A convenient clinical nomogram for predicting the cancer-specific survival of individual patients with small-intestine adenocarcinoma.
Wang N; Yang J; Lyu J; Liu Q; He H; Liu J; Li L; Ren X; Li Z
BMC Cancer; 2020 Jun; 20(1):505. PubMed ID: 32487033
[TBL] [Abstract][Full Text] [Related]
24. Web-Based Dynamic Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Breast Cancer Patients with Lung Metastases.
Wang K; Li Y; Wang D; Zhou Z
J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675704
[TBL] [Abstract][Full Text] [Related]
25. A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study.
Zhao W; Wu L; Zhao A; Zhang M; Tian Q; Shen Y; Wang F; Wang B; Wang L; Chen L; Zhao X; Dong D; Zhang L; Yang J
BMC Cancer; 2020 Oct; 20(1):982. PubMed ID: 33046035
[TBL] [Abstract][Full Text] [Related]
26. Risk factors and survival prediction of young breast cancer patients with liver metastases: a population-based study.
Pu CC; Yin L; Yan JM
Front Endocrinol (Lausanne); 2023; 14():1158759. PubMed ID: 37424855
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a nomogram to predict overall survival in young non-metastatic rectal cancer patients after curative resection: a population-based analysis.
Jia Z; Wu H; Xu J; Sun G
Int J Colorectal Dis; 2022 Nov; 37(11):2365-2374. PubMed ID: 36266551
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
Liang M; Chen M; Singh S; Singh S
Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
[TBL] [Abstract][Full Text] [Related]
29. Development and Verification of Prognostic Nomogram for Penile Cancer Based on the SEER Database.
Chen YB; Liu YW; Gao L; Tang LY; Guo J; Tian YC; You PH
Biomed Res Int; 2022; 2022():8752388. PubMed ID: 35419456
[TBL] [Abstract][Full Text] [Related]
30. Development of a prognostic nomogram for lymph node positive HR
Cheng X; Jiang J; Liang X; Zheng X
Gland Surg; 2023 Nov; 12(11):1541-1553. PubMed ID: 38107492
[TBL] [Abstract][Full Text] [Related]
31. Prognostic nomograms for predicting overall survival and cancer-specific survival of patients with very early-onset colorectal cancer: A population‑based analysis.
Dong B; Chen Y; Lyu G
Bosn J Basic Med Sci; 2022 Sep; 22(5):803-817. PubMed ID: 35348447
[TBL] [Abstract][Full Text] [Related]
32. Nomograms predict survival in elderly women with triple-negative breast cancer: A SEER population-based study.
Feng R; Huang W; Liu B; Li D; Zhao J; Yu Y; Cao X; Wang X
Technol Health Care; 2024 Jan; ():. PubMed ID: 38306071
[TBL] [Abstract][Full Text] [Related]
33. A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study.
Zhang H; Xie P; Li Z; Huang R; Feng W; Kong Y; Xu F; Zhao L; Song Q; Li J; Zhang B; Fan J; Qiao Y; Xie X; Zheng S; He J; Wang K
Diagn Pathol; 2019 May; 14(1):35. PubMed ID: 31054583
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a SEER-based prognostic nomogram for cervical cancer patients below the age of 45 years.
Liu Q; Li W; Xie M; Yang M; Xu M; Yang L; Sheng B; Peng Y; Gao L
Bosn J Basic Med Sci; 2021 Oct; 21(5):620-631. PubMed ID: 33485294
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a nomogram for predicting survival of breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
Lyu MH; Ma YZ; Tian PQ; Guo HH; Wang C; Liu ZZ; Chen XC
Chin Med J (Engl); 2021 Nov; 134(22):2692-2699. PubMed ID: 34743149
[TBL] [Abstract][Full Text] [Related]
36. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
[TBL] [Abstract][Full Text] [Related]
37. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.
Duan F; Song C; Ma Y; Jiang K; Xu F; Bi X; Huang J; Hong R; Huang Z; Lu Q; Yuan Z; Wang S; Xia W
Drug Des Devel Ther; 2021; 15():3463-3473. PubMed ID: 34408400
[TBL] [Abstract][Full Text] [Related]
38. A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer.
Pan WK; Ren SY; Zhu LX; Lin BC
Am J Clin Oncol; 2024 Feb; 47(2):71-80. PubMed ID: 37871164
[TBL] [Abstract][Full Text] [Related]
39. Nomogram for predicting the overall survival of patients with early-onset prostate cancer: A population-based retrospective study.
Hu Y; Qi Q; Zheng Y; Wang H; Zhou J; Hao Z; Meng J; Liang C
Cancer Med; 2022 Sep; 11(17):3260-3271. PubMed ID: 35322943
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors and survival prediction in HER2-positive breast cancer with bone metastases: A retrospective cohort study.
Lyu X; Luo B
Cancer Med; 2021 Nov; 10(22):8114-8126. PubMed ID: 34612593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
